Individuals with Return ED visits n = 10 | Individual with NO Return ED visits n = 186 | |
---|---|---|
Mean age (range) | 60.5 (28–90) | 54.7 (18–91) |
Male gender | 30% | 53.2% |
Insulin only ✻✝ | 4 [2.8% (CI 1.1–6.9%)] | 140 |
Long-acting alone | 1 | 11 |
Non long-acting alone* | 0 | 68 |
Both long-acting + non long-acting | 3 | 61 |
Long-acting ± non-long-acting* | 4 [5.4% (CI 2.1–12.7%)] | 72 |
Oral medication ± insulin✝ | 6 [11.5% (CI 5.4–22.9%)] | 46 |
Oral agent(s) alone✻ | 3 [15.8% (CI 5.5–37.5%)] | 16 |
Sulfonylurea monotherapy | 1 | 7 |
Non-sulfonylurea monotherapy | 0 | 2 |
Sulfonylurea + non-sulfonylurea | 2 | 7 |
Insulin + oral medication | 3 [9.1% (CI 3.1–23.6%)] | 30 |
Long-acting + sulfonylurea | 1 | 4 |
Long-acting + non-sulfonylurea | 2 | 4 |
Other combinations | 0 | 22 |